Messe Frankfurt India in collaboration with Andhra Pradesh Medtech Zone (AMTZ) hosted the forum were healthcare leaders deliberated upon the optimum infrastructure, regulatory framework and innovation in the Indian medical devices industry.
Talking about the recent changes that can be witnessed in the medical devices sector, Dr Uma Nambiar, Managing Director, Zeeden Life Sciences and Chairperson, Digital Health India Association (DHIA), said, “For various reasons we have not yet reached where we should because the big companies are traditionally centred in the west, but we have been outsourcing the devices to a lot of companies. We have seen revolution of sorts in the last two years owing to Government’s focus on ‘Aatmanirbhar Bharat’ and making India self-sufficient in many things related to healthcare, we have seen India transform from an importer of consumables in infectious disease treatment to the second largest exporter in the world within a span of one year. The same fate will also ensue in the medical devices industry.”
Dr Nambiar further added that improvement of regulatory framework in India and government’s push for innovation will take the medical devices industry forward.
Elaborating on the glowing opportunities that exist in the medical technology space, Dr Srikanth Sola, Founder, CEO and Director, Devic Earth Pvt Ltd, shared: “Within medical devices there are opportunities in diagnostics across adult paediatric ranges particularly in areas such as oncology, radiology, cardiology and other major specialties. There are also opportunities within medical therapeutics, devices, treatments and algorithms that help to predict when a patient is about to fall sick and help them get better. These devices include treatments that can be used in the hospital, within healthcare facilities for outpatient use and at home.”
The forum marking the presence of 192 delegates which had policy makers, national and international leaders from medical technology industry, academic and research fraternity to discuss major factors that impact the growth of the Indian medical devices industry, such as import dependency, need for more investment and collaborations.
Dr Jitendra Sharma, Managing Director and Chief Executive Officer, Andhra Pradesh Medtech Zone; Dr Manoj Chugh, Vice President & Head, Research and Development (Reagents), Transasia Bio-Medicals Ltd; Sudhakar Mairpadi, Head – Quality, Regulatory and Govt. Philips India Ltd. were amongst the prominent healthcare members who attended the two-day conference.